Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Small Cell Lung Carcinoma 9Carcinoma, Non-Small-Cell Lung 7Sarcoma 5Breast Neoplasms 4Triple Negative Breast Neoplasms 3Nasopharyngeal Carcinoma 3Thyroid Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Whole-Brain Radiotherapy 1Stomach Neoplasms 1Solid Tumors 1Small Cell Lung Cancer Extensive Stage 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Proteinuria 1Progression Free Survival(PFS) 1Platinum-resistant Ovarian Cancer (PROC) 1Ovarian Neoplasms 1Lung Neoplasms 1Leiomyosarcoma 1HER2-Negative Breast Cancer 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Extensive Stage Lung Small Cell Cancer 1Esophageal Neoplasms 1

Interventions

Paclitaxel 40Carboplatin 34Bevacizumab 29liposomal doxorubicin 20Specimen Handling 18Taxes 17olaparib 16Magnetic Resonance Spectroscopy 16pembrolizumab 15Gemcitabine 15Topotecan 13Immunoglobulin G 11Disulfides 11Biopsy 11mirvetuximab soravtansine 8niraparib 7Nivolumab 7Doxorubicin 7Cyclophosphamide 6Cisplatin 6Drug Therapy 5130-nm albumin-bound paclitaxel 5cemiplimab 4cediranib 4Letrozole 4Injections 4Docetaxel 41-dodecylpyridoxal 4sarilumab 3rucaparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × anlotinib × 1 year × Clear all
NCT07489300 2026-03-24

BACON

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Not yet recruiting
40 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡